The auto major today reported a steep 20 per cent fall in net profit to Rs 766 crore in the June quarter as sales were crimped by GST transition while revenue inched up 3.3 per cent to Rs 12,335.56 crore.
At the company's 71st AGM here, shareholders expressed concern about rising competition in the SUV segment where Mahindra used to be the leader till some years ago.
"But we will focus on growth, success of our products, increase in volume and increase in our profitability. We want to be winners in our segment which is our goal. Our products have longer life and I think we are going to win the race in the long-run," Mahindra told the shareholders.
Stating that the whole industry has been facing a downturn, he said, "Like almost everyone else, we too faced some hitches, mainly due to liquidity crunch which affected our partners and customers. But we were quick to recover and our sales have risen (since the note ban)."
Mahindra also allayed fears of the shareholders on the company exiting the European electric car market, saying it is only re-adjusting its strategy.
"We believe the European market has moved to a higher range, beyond the original demand that used to have for our small Reva offering. We will return to that market when we've a right product."
"We are coming out with some premium bikes and are reworking our strategy. You will see that happening soon. These are very high-end premium products which will be our focus," he said.
Earlier, talking to reporters about the steep 20 per cent fall in Q1 profit, M&M managing director Pawan Goenka said the June quarter was quite eventful, starting with BS III ban and followed by the GST transition. The industry, though, has managed these disruptions quite well, he said.
The GST rollout resulted in a one-time hit of Rs 144 crore by way of dealer support in respect of duty paid on goods lying with them, he said.
Sounding bullish on sales front, he said the company will have new activities starting next month when it will roll out a new utility vehicle U321 and a few variants of the existing line-ups.
"Our focus is firmly on the UV, SCV and LCV segments. In SCVs, we've a market share of close to 52 per cent and expect it to further improve. In HCVs, we are on a growth path, especially after BS-IV. Yes, there is some struggle in the UV segment, where we have had de-growth in our market share. And that is where most of our focus will be," Goenka said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
